We are live on
!
Find out more
EAM
EULAV Asset Management Portfolio holdings
AUM
$3.13B
1-Year Est. Return
23.04%
This Fund
S&P 500
This Quarter
Est. Return
+12.09%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$4.26B
AUM Growth
+$210M
(+5.2%)
Cap. Flow
-$142M
Cap. Flow
% of AUM
-3.33%
Top 10 Holdings %
Top 10 Hldgs %
26.51%
Holding
166
New
1
Increased
41
Reduced
49
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roper Technologies
ROP
|
+$18.8M |
| 2 |
Applovin
APP
|
+$14.3M |
| 3 |
Eli Lilly
LLY
|
+$7.38M |
| 4 |
Teledyne Technologies
TDY
|
+$6.66M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
+$6.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TransDigm Group
TDG
|
+$64M |
| 2 |
Adobe
ADBE
|
+$25.9M |
| 3 |
EPAM Systems
EPAM
|
+$11.6M |
| 4 |
Cintas
CTAS
|
+$10.6M |
| 5 |
Uber
UBER
|
+$10.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.03% |
| 2 | Industrials | 25.42% |
| 3 | Financials | 15.21% |
| 4 | Healthcare | 11.2% |
| 5 | Consumer Discretionary | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Enpro
NPO
$6.26B
| $2.53M | 0.06% |
13,200
| – | – |
|
152
Qualcomm
QCOM
$164B
| $2.39M | 0.06% |
15,028
-2,972
| -17% | -$438K |
|
153
PayPal
PYPL
$50.3B
| $2.38M | 0.06% |
32,000
| – | – |
|
154
DexCom
DXCM
$29B
| $2.36M | 0.06% |
27,016
+1
| +0% | +$78 |
|
155
BioMarin Pharmaceuticals
BMRN
$11.9B
| $2.09M | 0.05% |
38,000
-67,000
| -64% | -$3.95M |
|
156
Prestige Consumer Healthcare
PBH
$2.47B
| $1.55M | 0.04% |
19,400
| – | – |
|
157
Herc Holdings
HRI
$4.78B
| $1.07M | 0.03% |
8,100
| – | – |
|
|
EFOR
158
Everforth Inc
EFOR
$960M
| $1M | 0.02% |
20,100
| – | – |
|
159
Workiva
WK
$3.45B
| $815K | 0.02% |
11,900
-64,500
| -84% | -$4.44M |
|
160
Littelfuse
LFUS
$10.4B
| $683K | 0.02% |
3,013
+13
| +0.4% | +$2.56K |
|
|
161
Adobe
ADBE
$105B
| – | – |
-67,401
| Closed | -$25.9M |
|
|
162
EPAM Systems
EPAM
$5.58B
| – | – |
-68,660
| Closed | -$11.6M |
|
163
FTI Consulting
FCN
$5.14B
| – | – |
-37,500
| Closed | -$6.15M |
|
164
lululemon athletica
LULU
$13.5B
| – | – |
-20,000
| Closed | -$5.66M |
|
165
Constellation Brands
STZ
$22.5B
| – | – |
-13,000
| Closed | -$2.39M |
|
166
US Physical Therapy
USPH
$1.22B
| – | – |
-19,100
| Closed | -$1.38M |
|
Similar funds
LFG
BI
GKWIM
DIG
BP
CCI
PC
TCG
EULAV Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, EULAV Asset Management held 166 positions worth $4.26B, up 5.2% from $4.05B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
EULAV Asset Management withdrew a net $142M in Q2 2025, closing 6 positions and reducing 49 holdings. Its most notable exit was Adobe, an estimated $25.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Industrials and Financials.
Against the trend, EULAV Asset Management opened a new position in Eli Lilly worth $7.41M.
- EULAV Asset Management's largest Q2 2025 buy was Eli Lilly: 9,500 shares worth $7.41M.
- EULAV Asset Management added most to Roper Technologies in Q2 2025, an estimated $18.8M increase.
- EULAV Asset Management's biggest Q2 2025 reduction was TransDigm Group, cutting an estimated $64M.
- EULAV Asset Management fully exited Adobe in Q2 2025, selling an estimated $25.9M.
- EULAV Asset Management's ten largest holdings make up 27% of its $4.26B portfolio in Q2 2025.
- EULAV Asset Management opened 1 new position and closed 6 in Q2 2025.
- EULAV Asset Management's portfolio value rose 5.2% quarter-over-quarter to $4.26B.
Based on EULAV Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.